According to Pharmanutra's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.96. At the end of 2024 the company had a P/S ratio of 4.32.
Year | P/S ratio | Change |
---|---|---|
2024 | 4.32 | -20.5% |
2023 | 5.44 | -25.94% |
2022 | 7.34 | -29.16% |
2021 | 10.4 | 56.84% |
2020 | 6.61 |